UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care building, Irvine
University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange

Тражи се учесникФаза 2/3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07100080

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Beverly Hills Cancer Center ( Site 0142), Beverly Hills

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07190248

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
Providence St. Jude Medical Center, Fullerton
и још 1

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Tower Cancer Research Foundation, Beverly Hills
Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
и још 20

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

BostonGene and Exigent Genomic INsight Study

Stockton Hematology Oncology Medical Group, Stockton

Тражи се учесникОпсервациона студија

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06272864

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Kaiser Permanente-Anaheim, Anaheim
Kaiser Permanente-Deer Valley Medical Center, Antioch
Sutter Auburn Faith Hospital, Auburn
и још 56

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

CBCC Global Research, Inc. ( Site 0123), Bakersfield
Beverly Hills Cancer Center ( Site 0116), Beverly Hills

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06345729

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Clinical Research Advisors, LLC, Beverly Hills

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06472245

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

City of Hope-Duarte-56419, Duarte
Valkyrie Clinical Trials, Los Angeles
University of California Irvine, Orange
и још 1

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04886804

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

City of Hope - Duarte Cancer Center, Duarte
UCLA Health Bowyer Oncology Center, Los Angeles
UCSF Helen Diller Medical Center at Parnassus Heights - Neurology, San Francisco
и још 1

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06914128

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Cedars-Sinai Medical Center, Los Angeles

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07020221

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Beverly Hills Cancer Center ( Site 0070), Beverly Hills
UCLA Clinical & Translational Research Center (CTRC) ( Site 0033), Los Angeles
Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
и још 2

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06312137

A Study of DS-3939a in Participants With Solid Tumors

UCLA Health, Los Angeles

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07739966

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Ellison Institute, Los Angeles

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT04557449

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

City of Hope Comprehensive Cancer Center, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07503808

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

Local Institution - 0212, Beverly Hills
Local Institution - 0504, Fullerton
Local Institution - 0357, La Jolla

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07680790

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Duarte
Research Site, Irvine
Research Site, La Jolla
и још 3

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07291037

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

St. Jude Herritage Medical Group, Fullerton
Hoag Family Cancer Institute - Hoag Memorial Hospital, Newport Beach
Sutter Institute for Medical Research, Sacramento

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06216301

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Providence St. Jude Medical Center ( Site 0106), Fullerton
VA Long Beach Healthcare System ( Site 0199), Long Beach
USC Norris Comprehensive Cancer Center ( Site 0205), Los Angeles
и још 2

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06623422

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

UC Davis Comprehensive Cancer Center ( Site 3204), Sacramento

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07513376

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

Community Cancer Institute (CCI), Clovis

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07541170

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
UCLA Hematology/Oncology - Santa Monica, Santa Monica

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06561386

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

Oncura Health d.b.a.Los Angeles Cancer Network, Glendale
UCLA Health - Santa Monica Cancer Care, Los Angeles
UCSF Health - UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07566052

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

UC Irvine Health, Orange

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT06881784

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Providence Medical Group, Santa Rosa

Тражи се учесникФаза 1

Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT06983743

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Oncura Health, Glendale
UC San Diego Health - Moores Cancer Center, La Jolla
California Research Institute, Los Angeles
и још 4

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

UCLA Hematology/Oncology - Alhambra, Alhambra
UCLA Hematology/Oncology - Atascadero, Atascadero
Alta Bates Summit Medical Center Comprehensive Cancer Center, Berkeley
и још 35

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07144280

A 2-part Phase 1/2 Open-label Trial on ODM-212

Valkyrie Clinical Trials, Los Angeles
UC Irvine Health, Orange

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07563738

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
Administrative Address: UCLA Hematology/Oncology, Los Angeles
и још 3

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07090499

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Kaiser Permanente-Anaheim, Anaheim
Kaiser Permanente-Baldwin Park, Baldwin Park
Kaiser Permanente-Bellflower, Bellflower
и још 15

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07388524

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Community Cancer Institute (CCI), Clovis
Marin Cancer Care Inc, Greenbrae
UCI Health-CIACC, Irvine
и још 6

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06793215

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

City of Hope, Duarte, Duarte
City of Hope Lennar, Irvine
UCLA Hematology/Oncology - Santa Monica, Los Angeles
и још 5

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06890598

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Stanford Cancer Institute, Palo Alto

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06150664

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

The Regents of the University of California - Irvine, CA Campus, Irvine
UC San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Cancer at Cedars Sinai Medical Center, Los Angeles
и још 2

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06706076

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

University of California Los Angeles Medical Center, Los Angeles
University of California, San Diego; Moores Cancer Center, San Diego
USOR Sansum Clinic, Santa Barbara
и још 1

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05579366

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.